Addiction

Leading Computational Scientist and Oncology Researcher Elana Fertig, PhD, Appointed New Director of Institute for Genome Sciences

Internationally-recognized for her work in developing predictive models for drug resistance in cancer treatment BALTIMORE, Aug. 30, 2024 /PRNewswire/ --…

3 months ago

RELEASE RECOVERY ACQUIRES LEADING MEN’S PERSONAL WELLBEING PLATFORM MANUAL TO EXPAND NATIONAL REACH AND OFFER MORE COMPREHENSIVE SERVICES

New Entity Combines Release Recovery's Best in Class Behavioral Health Care Services to Include MANUAL's Technology Platform and College Campus…

3 months ago

Awakn Announces Key Progress in Its Aminoindane Pre-Clinical Program

Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - Awakn Life Sciences Corp. (CSE: AWKN) (OTCQB: AWKNF), a clinical-stage biotechnology company…

3 months ago

Mahajan Therapeutics Unveils Brand Refresh

LEWISVILLE, Texas, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Mahajan Therapeutics, Ohio’s premier provider of mental health and addiction health services,…

3 months ago

PRIMEFOCUS AND MARSHALL HEALTH NETWORK COLLABORATE ON NEW HEALTHCARE SERVICE SOLUTION

HUNTINGTON, W.Va., Aug. 26, 2024  /PRNewswire/ -- Marshall Health Network, Inc., a leading West Virginia-based academic health system, announces a new…

3 months ago

KindlyMD(TM) Appoints Nancy Pratt as Behavioral Health Program Director

Ms. Pratt, a seasoned mental health counselor with extensive academic and practical experience, will enhance the Company's Complete Care and…

3 months ago

Tonix Pharmaceuticals Announces First Patient Enrolled in Phase 2 CATALYST Study of TNX-1300 for the Treatment of Cocaine Intoxication

CATALYST is a Phase 2 single-blind, placebo-controlled, proof-of-concept study in patients presenting to the emergency department More than 27,569 individuals…

3 months ago

KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update

Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid,…

3 months ago

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

GLEN ALLEN, Va., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage…

3 months ago